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ABSTRACT  
Objective: This study aimed to develop quality indicators for assessing pharmaceutical care performance in the Nigerian community pharmacies.  
Methods: We searched for existing quality indicators through an extensive literature review. The identified quality indicators consisted of 
thirty-four items in 10 core components. The Delphi method was used to arrive at a consensus on quality indicators for assessing 
pharmaceutical care performance in the Nigerian community pharmacies by surveying a panel of experts. There were 3 rounds of the Delphi 
panel conducted by consulting a panel of 10 experts in pharmaceutical care practice. A mean score>3.5, median>3.5, an absolute value between 
the median and mode<1.00 was used to establish consensus on the quality indicators for assessing pharmaceutical care performance in the 
Nigerian community pharmacies. 
Results: Ten studies met the inclusion criteria. A list of 33 quality indicators comprising of 10 core components emerged from the extensive 
literature review. They included quality management, documentation of care, communication with the patient, management of clinical risk in 
pharmacy, compounding, dispensing and patient care, follow-up of pharmacotherapy counselling, drug inventory and stocking, training of 
pharmaceutical staff. At the end of the round three votings, 24 statements of the quality indicator reached consensus in nine core components: 
quality management (5), continuity of care (1), communication with patients (3), clinical risk management (5), dispensing (1), follow-up of 
pharmacotherapy (3), counselling (1), logistics (3), training of pharmacy staff (2). 
Conclusion: This study developed a set of 24 quality indicators for assessing pharmaceutical care performance in community pharmacies in 
Nigeria
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INTRODUCTION 
Pharmaceutical care is a philosophy of practice for pharmacists. The 
concept tasks pharmacists to assume responsibility with other 
health professionals to ensure patients positive health outcomes. 
Pharmaceutical care practice leads the pharmacist to access the 
therapy received by patients for appropriateness, identify drug-
related problems and resolve the identified drug-related problem. 
Besides medication supervision, pharmaceutical care practice 
encourages pharmacists to undertake patients counselling [1, 2].  
Several barriers to pharmaceutical care practice have been 
documented in the literature [3, 4]. Lack of standards for 
pharmacists to apply in their daily practice is the main obstacle 
to pharmaceutical care implementation [3]. Thus, it is important to 
establish practice standards to aid pharmaceutical care practice. 
Such practice standards should be environment-specific while 
following the general norms of pharmaceutical care practice. This is 
important given the peculiarities of community pharmacy practice 
in Nigeria. One of such being that community pharmacy co-exists 
with drug vendors who do not have formal pharmacy training and 
are authorized to sell only over the counter drugs. 
The Delphi method was used to achieve consensus on quality 
indicators for assessing pharmaceutical care performance in the 
Nigerian community pharmacies by surveying a panel of experts. 
RAND Corporation developed Delphi technique in Santa Monica, 
California, in the 1950s during the Cold War when the US devised a 
Delphi project to forecast the impact of technology on military 
capabilities’ development [5]. Delphi technique is a research design 
that uses a series of questionnaires to gain consensus involving 
multiple iterations to get information and results from panel 
members between each round [5, 6]. To regard a procedure as 
Delphi, four features are necessary. These features include iteration, 
controlled feedback, anonymity and statistical analysis of responses 
[5, 7].  
Quality indicators rate the quality of care provided by healthcare 
professionals. They deal with the characteristics of service 
providers, steps involved in providing care, and the effect of care 
on the health status [8]. Quality indicators are used to enhance 
quality improvement activities by either making comparison 
between institutions over time or by supporting consumers to 
choose their health care providers [9]. Absence of quality 
indicators in health care services is disastrous and highly 
unprofessional as they are needed to assess and improve the 
quality of medical practice [10].  
To the best of our knowledge, there is no set of quality indicators 
available to assess
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 pharmaceutical care performance in community 
pharmacies in Nigeria. Therefore, this study used a Delphi panel to 
develop Nigerian specific quality indicators for assessing 
pharmaceutical care performance in community pharmacies. 
Methods  
We searched for existing quality indicators developed for assessing 
pharmaceutical care performance in community pharmacies 
through an extensive literature review. Studies that were selected 
for inclusion included: (1) studies that developed quality indicators 
for pharmaceutical care practice; (2) studies that reported the 
impact of the quality indicators on community pharmacy practice; 
and (3) studies published in the English language. We excluded 
studies that reported only abstracts or literature review of the 
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research work and studies that assessed only one aspect of 
pharmaceutical care practice. 
After reviewing the selected studies, we selected 33 quality 
indicators comprising ten components [11-19]. The ten components 
were quality management, documentation of care, communication 
with the patient, management of clinical risk in pharmacy, 
compounding, dispensing and patient care, and follow-up of 
pharmacotherapy, counselling, drug inventory and stocking, training 
of pharmacy staff.  
Selection and description of participants 
The researchers identified the criteria required in choosing the 
panel of experts before the Delphi panel. Pharmacists with 
knowledge and experience of pharmaceutical care practice in a 
community pharmacy were selected as experts. Some 
administrators of pharmacy practice were also included as members 
of the panel of experts. Specifically, the Anambra State Pharmacist 
Council of Nigeria (PCN) officer, the Director of Pharmaceutical 
Services (DPS), the Deputy Director of Pharmaceutical Services 
(DDPS) and community pharmacists who were members of the 
pharmacy inspection and regulation team represented the panel of 
experts. In total, ten panels of experts participated in this study. A 
study stated that ten to fifteen panels of experts are needed to yield 
satisfactory results for a study using the Delphi method 
[20]. Another study suggested that 5 to 10 experts are adequate for 
content validation [21]. 
There were three rounds of the Delphi panel for this study. In 
the first round, the participants received a questionnaire 
containing the list of indicators with clear and specific 
instruction for each participant. Table 1 shows the list of 
indicators distributed in the first round of the Delphi panel. The 
participants voted by either ticking agree or disagree beside 
each statement. 
Technical information 
The experts were also given the opportunity to offer comments 
and suggested more items necessary in developing the 
questionnaire. The response frequencies were anonymously 
calculated. A statement needs 80% of the panel of experts to agree 
to it (that is 8 out of 10 experts) to be accepted at each round. This 
was based on a study which suggested that at least 80% of experts 
(in a case where 10 experts participated in a consensus study) 
must agree on an item to meet consensus [21].  
According to the feedback received from the panelists, the 
statements that did not meet the 80% consensus got rephrased 
and the instrument summarized for the second round of the 
Delphi panel. In round 2 of the Delphi panel, the 10 panels of 
experts received the summarized questionnaire from round 1. The 
experts used the same voting methods described in round 1 but 
with the knowledge of the expert’s earlier scores and comments. 
The participants could change their minds on their votes while 
reflecting on the group’s result and yet their responses were 
recorded anonymously. Analysis of the responses was as in round 
1 of the Delphi panel. The researcher deleted all statements that 
did not meet the experts’ agreement from the questionnaire. Some 
statements got adjusted based on the feedback from the experts 
and the instrument summarized for the third round. In the third 
and last round of the Delphi panel, the participants received the 
questionnaire in a Likert
Ethics 
 scale format with instruction to vote the 
degree to which they agree with the indicators using a 5-point 
scale where 1 meant the idea was highly irrelevant and 5 meant 
the idea was highly relevant. The goal of the third round was to 
gain consensus. At the end of the third round, the Delphi 
procedure was considered completed [22].  
The Ethics Committee of Chukwuemeka Odumegwu Ojukwu 
University Teaching Hospital Awka, Anambra State, Nigeria, 
approved the study (COOUTH/CMAC/ETH. C/VOl.1/0068). 
Participants gave their informed consent before the commencement 
of the study. 
Statistical analysis 
In the third round of the Delphi panel, indicators considered valid 
were those that met the following criteria: (1) 80% of the 
participants rated three or higher on a 5-point scale; (2) the mean 
score on the Likert scale was>3.5; (3) the median on the Likert
RESULTS  
 scale 
was>3.5; and (4) the absolute value of the difference between the 
median and the mode was<1.00 [5, 6, 7, 23].  
Ten studies met the inclusion criteria and were used to generate a 
set of potential quality indicators [11-19]. A list of 33 quality 
indicators comprising ten components emerged from the summary 
findings. The ten components were: quality management, 
documentation of care, communication with the patient, 
management of clinical risk in pharmacy, compounding, dispensing 
and patient care, follow-up of pharmacotherapy counselling, drug 
inventory and stocking, training of pharmacy staff At the end of 
round 1 voting and after summarizing the comments made by the 
experts, a consensus was reached for twenty-five out of the thirty-
three quality indicators (i.e. ≥ 8 panel members voted “agree” for 
each of the 25 statements). These 25 quality indicators were from 
nine components. These quality indicators got approved for the next 
round. Consensus was not reached for eight of the quality indicators 
after round 1 (i.e. ≥ 8 panel members voted “disagree” on the 
statement). The eight quality indicators included: documented 
errors that did reach the patients; documented errors reported to 
the physician or primary care provider; patients offered instructions 
on inhalation medication and use with first dispensing; availability 
of a standard operating procedure for the release of compounded 
medication before dispensing of the drug to the patient; medication 
compounded for each patient that followed standardized procedure; 
dosage of the compounded medication for children (0 to 6 y) cross-
checked by a pharmacist; expired medication dispensed to the 
patient and thus discovered and reported by the patient (each 
month) and participation in a national program for the patient-
reported side effect of drugs in the National Pharmacovigilance
In round 2, the panel of experts received the 25 statements of the 
quality indicator that reached consensus together with the eight 
statements that did not reach consensus in round 1 with the 
accompanying comments. After round 2 voting, the experts reached 
consensus on 24 statements (i.e. ≥ 8-panel members voted “agree” 
on the 24 statements). The panel also reached consensus to omit 
nine statements from the questionnaire (i.e. ≥ 8-panel members 
voted “disagree” on the nine statements). Consensus was not 
reached for a total of nine statements after round 2. Table 2 gave 
details of the second round of the Delphi panel.  
 
Center. 
The aim of round 3 was to seek clarification for statements that 
reached consensus and generate more statements that will help 
in developing the quality indicators. In round three, a consensus 
was reached for the 24 statements of the indicators after voting 
(i.e. ≥8 of the participants’ votes rated 3 or higher on a 5-point 
scale; the mean score on the Likert scale was>3.5; the median on 
the Likert scale was>3.5; and the absolute value of the difference 
between the median and the mode was<1.00).  
  
The final list of quality indicators consisted of 24 statements 
distributed in nine components. Five statements related to 
quality management, one statement related to continuity of care, 
three statements related to communication with the patient, five 
statements related to clinical risk management, one statement 
related to dispensing, three statements related to follow-up of 
pharmacotherapy, one statement related to counselling, three 
statements related to logistics, and two statements related to 
training of pharmacy staff. Table 3 shows the result of the third 
round of the Delphi panel. 
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Table 1: Quality indicator obtained after the first round of delphi technique 
Quality management  
1. The number of years of practice as a pharmacist. 
2. The number of patient-reported adverse effects that were reported to the national pharmacovigilance center. 
Documentation of care  
1. Pharmacist ability to obtain information on patients’ actual use of the drug before dispensing and to document all the necessary information 
obtained in the patients’ record. 
2. A standard means of documenting medication errors (e. g. wrong dosage, wrong substance, wrong compounding) that occurred during the work 
process in the pharmacy and was realized before the drug reached the patient.  
3. The number of medication errors discovered during dispensing of medications that were effectively documented. 
4. Complaints made by patients that were documented by the pharmacist. 
5. The number of documented errors that reached the patient. 
6. Formal documentation of allergic reactions. 
Communication with patient  
1. The number of patients who were given instructions on the use of inhalation medication with first dispensing.  
2. An educational program and plan are mapped out for each patient, especially patients with chronic diseases. 
3. Drug information adequately provided by the pharmacist to patients chronically taking 3 classes of drugs concomitantly. 
4. The number of patients adequately educated on drug interactions (drug-drug, drug-food interactions). 
Management of clinical risk in pharmacy  
1. Stipulated guidelines were implemented in managing clinical risks in the pharmacy. 
2. There is formal documentation of all action taken when a drug interaction occurs. 
3. A protocol is available for informing patients on contraindication of drugs especially new patients.  
4. Management and formal documentation of patients drug allergic reactions, most especially new patients. 
5. Referral of patients to other healthcare providers and effective documentation. 
Compounding  
1. Compounded medications were produced after undergoing standard operating procedure before being dispensed to patients.  
2. The number of drugs compounded for patients that followed standard procedure. 
3. Dosage of compounded mediation for children (0 to 6 y) is checked by the pharmacist. 
Dispensing and patient care  
1. The number of dispensed medication with the patient given information on the drug. 
2. Dispensed medication cross-checked by the pharmacist (percentage). 
Follow up of pharmacotherapy  
1. Percentage of patients using NSAIDs, especially elderly patients (>70 y), also received gastroprotection. 
2. The pharmacist ensures that gastroprotection was added to drugs of patients on NSAIDs in 80% of cases, especially patients>70 y where 
gastroprotection was lacking. 
3. The number of patients followed up on pharmacotherapy and documented. 
Counselling  
1. A professional guideline was employed while counseling patients on medication. 
Drug inventory and stocking  
1. A professional guideline was employed in assessing suppliers of drugs. 
2. There is a standard system for checking expired drugs. 
3. The number of drugs that were discovered to have expired internally before being dispensed each month. 
Training of pharmaceutical staff  
1. Participation in mandatory professional development courses, seminars and continuing education for pharmacists. 
2. Percentage of pharmaceutical staff with adequate training in pharmacy operations. 
3. The side effect of drugs reported by patients was entered into a national program in the national pharmacovigilance centre. 
 
Table 2: Quality indicator obtained after the second round of Delphi technique 
Quality management  
1. The number of years of practice as a pharmacist. 
2. The number of patient-reported adverse effects that were reported to the national pharmacovigilance center. 
Documentation of care  
1. Pharmacist ability to obtain information on patients’ actual use of a drug before dispensing and to document all the necessary information 
obtained in the patients’ record. 
2. A standard means of documenting medication errors (e. g. wrong dosage, wrong substance, wrong compounding) that occurred during the work 
process in the pharmacy and was realized before the drug reached the patient.  
3. The number of medication errors discovered during dispensing of medications that were effectively documented. 
4. Complaints made by patients that were documented by a pharmacist. 
5. The number of documented errors that reached the patient. 
6. Formal documentation of allergic reactions. 
Communication with patient  
1. The number of patients who were given instructions on the use of inhalation medication with first dispensing.  
2. An educational program and plan are mapped out for each patient, especially patients with chronic diseases. 
3. Drug information adequately provided by the pharmacist to patients chronically taking 3 classes of drugs concomitantly. 
4. The number of patients adequately educated on drug interactions (drug-drug, drug-food interactions). 
Management of clinical risk in pharmacy  
1. Stipulated guidelines were implemented in managing clinical risks in the pharmacy. 
2. There is formal documentation of all action taken when a drug interaction occurs. 
3. A protocol is available for informing patients on contraindication of drugs especially new patients.  
4. Management and formal documentation of patients drug allergic reactions, most especially new patients. 
5. Referral of patients to other healthcare providers and effective documentation. 
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Compounding  
1. Compounded medications were produced after undergoing standard operating procedure before being dispensed to patients.  
2. The number of drugs compounded for patients that followed standard procedure. 
3. Dosage of compounded mediation for children (0 to 6 y) is checked by the pharmacist. 
Dispensing and patient care  
1. Number of dispensed medication with the patient given information on the drug 
2. Dispensed medication cross-checked by the pharmacist (percentage) 
Follow up of pharmacotherapy  
1. Percentage of patients using NSAIDs, especially elderly patients (>70 y) also received gastroprotection. 
2. The pharmacist ensures that gastroprotection was added to drugs of patients on NSAIDs in 80% of cases, especially patients>70 y where 
gastroprotection was lacking. 
3. The number of patients followed up on pharmacotherapy and documented. 
Counselling  
1. A professional guideline was employed while counselling patients on medication. 
Drug inventory and stocking  
1. A professional guideline was employed in assessing suppliers of drugs. 
2. There is a standard system for checking expired drugs. 
3. The number of drugs that were discovered to have expired internally before being dispensed each month. 
Training of pharmaceutical staff  
1. Participation in mandatory professional development courses, seminars and continuing education for pharmacists. 
2. Percentage of pharmaceutical staff with adequate training in pharmacy operations. 
3. The side effect of drugs reported by patients was entered into a national program in the national pharmacovigilance centre. 
 
Table 3: Result of rating indicator in the third round 
Components and indicators Consensus 
  Mean Median (Me-Mo) Status  
Quality management      
Number of years of practice as a community pharmacist 3.7 4 0.0 valid 










Documentation of care     
The ability of the pharmacist to obtain information on patients’ actual drug use before dispensing 









A standard means of documenting medication errors (e. g. wrong dosage, substance, wrong 
compounding) that occurred during the work process in the pharmacy and was realized before the 





























Communication with patient     










Drug information is adequately provided to patients currently in chronic consumption of 3 









Number of patients adequately educated on drug interactions (drug-drug, drug-food interactions).  4.3 4.5 0.5 valid 
Management of clinical risk in pharmacy     
Stipulated guidelines were employed in clinical risks management in pharmacy 4.5 4 0.0 valid  
In case of a drug interaction, actions taken are formally documented. 4.4 5 0.0 valid 
There is a protocol available to inform patients on drug contraindications 









Allergic reactions are managed effectively for all patients, especially for new Patients. 4.3 4 0.0 valid  
Referral of patients to other healthcare providers and effective documentation. 4.2 4 0.0 valid  
Dispensing and patient care      
Number of dispensed medication with the patient given Information on the drug. 3.6 4 0.0 valid 
Follow up of pharmacotherapy     
The number of NSAID users whom gastro protection was administered, especially patients>70 y old.  4.1 4 0.0 valid 
The pharmacist provided gastro protection especially to patients>70 y who are using NSAIDs on a 









Number of patients followed up on pharmacotherapy and documented. 4.2 4 0.0 valid 
Counselling      
A professional guideline was employed while counselling patients on medications 4.4 4 0.0 valid 
Drug inventory and stocking     
Suppliers of drugs assessed according to the professional guideline 4.1 4 0.0 valid 
There is a standard system for checking expired drugs 4.4 5 0.0 valid  
The number of drugs discovered to have expired and reported before they were 









Training of pharmaceutical personnel     










Percentage of pharmaceutical staff with adequate training on pharmacy operations 4.0 4 0.0 valid 
Valid= Accepted; ×= Rejected; (Me-Mo) = Median-Mode 
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DISCUSSION 
The study developed a set of quality indicators for assessing the 
pharmaceutical care performance of community pharmacies in Nigeria. 
The set of quality indicators covers a great range of community 
pharmacy practice. The experts in community pharmacy practice and 
major stakeholders in community pharmacy practice reached a 
consensus on the quality indicators for assessing pharmaceutical care 
performance in the Nigerian community pharmacies.  
It has been opined that quality indicators for assessing the 
performance of a healthcare delivery system should be selected 
based on inputs of health care providers with adequate knowledge 
and experience [14]. Since the late 1970s, Delphi technique has been 
employed for such exercise e. g. selecting quality indicators [34]. 
There are quality indicators developed for specific disease states 
[24-33]. Since the late 1970s, quality indicators in health care have 
been arrived at with the use of the Delphi technique [34]. For 
instance, a study revealed the effectiveness of the Delphi panel in 
establishing consensus in developing prescribing indicators [25], 
developing indicators for chronic diseases [35], developing 
performance indicators for emergence medicine [36] and 
developing indicators for laboratory performance [33]. In our study, 
we used the Delphi technique to develop a tool for assessing the 
performance of community pharmacists concerning their 
pharmaceutical care delivery. A panel of ten experts in the 
pharmaceutical sector conducted a three-round Delphi panel. The 
panel of experts reached consensus on twenty-four quality 
indicators in nine core components, including quality management 
(2 indicators), documentation of care (4 indicators), communication 
with patients (3 indicators), management of clinical risk in 
pharmacy (5 indicators), dispensing and patient care (1 indicator), 
follow-up of pharmacotherapy (3 indicators), counselling (1 
indicator), drug inventory and patient care (3 indicators), training of 
pharmaceutical staff (2 indicators). The number of quality indicators 
that resulted in our study is fewer to those obtained from the study 
by [14] in the Netherlands. The Netherlands study developed 42 
quality indicators for community pharmacy care. The indicators 
included the following: patient counselling (6 indicators), clinical 
risk management (10 indicators), compounding (7 indicators), 
dispensing (3 indicators), monitoring of medication use (11 
indicators), quality management (5 indicators). Another study [12] 
developed 66 quality indicators across 10 categories. The difference 
in the number of quality indicators of these studies compared to 
ours could be explained in part by the lesser standards of care 
typically obtainable in developing settings. Nevertheless, 
introducing these 24 indicators is an important step towards 
improving pharmaceutical care practice in community pharmacies 
in Nigeria. The major stakeholders in pharmacy practice 
participated in validating the questionnaire and this will increase its 
validity and possibly its acceptance for use in the Nigerian 
context. Furthermore, the acceptance and popularity of the quality 
indicators will depend on its proper use, feedback from the 
community pharmacists and the use of the indicator by the 
pharmacy inspection team during their routine inspection.  
CONCLUSION  
This study had some possible limitations which could have emanated 
from the prominent disadvantages of the Delphi technique, such as 
‘‘bandwagon effect,’’ ‘‘noise,’’ and ‘‘peer pressure for conformity’’. We 
tried to avoid these limitations by successfully protecting each expert's 
identity with strict confidentiality and by avoiding personal contacts 
among experts. Additionally, ‘‘respondent’s fatigue’’ was minimized by 
limiting the Delphi rounds to only three. 
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